27.54
-1.46 (-5.03%)
-1.46 (-5.03%)
Upgrade to Real-Time
Afterhours
| Volume | 27,408 |
|
|||||
| News | - | ||||||
| Day High | 29.08 | Low High |
|||||
| Day Low | 27.2035 | ||||||
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Level 1 Starter
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Tarsus Pharmaceuticals Inc | TARS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
 |
|
|---|---|---|---|---|
| -1.46 | -5.03% | 27.54 | 18:00:16 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 29.07 | 27.2035 | 29.08 | 27.54 | 29.00 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,214 | 27,408 | $ 27.85 | $ 763,324 | - | 17.96 - 63.69 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:35:24 | formt | 140 | $ 27.54 | USD |
Period:
Draw Mode:
Tarsus Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 566.61M | 20.57M | 8.84M | $ - | $ - | -4.52 | -8.70 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | -5.93k | 7.50% |
Tarsus Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical TARS Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 28.95 | 29.44 | 26.48 | 28.21 | 30,853 | -1.41 | -4.87% |
| 1 Month | 22.70 | 30.9999 | 21.00 | 26.81 | 34,226 | 4.84 | 21.32% |
| 3 Months | 23.50 | 30.9999 | 21.00 | 25.22 | 29,197 | 4.04 | 17.19% |
| 6 Months | 32.74 | 39.08 | 21.00 | 28.78 | 50,129 | -5.20 | -15.88% |
| 1 Year | 21.80 | 63.69 | 17.96 | 33.47 | 58,693 | 5.74 | 26.33% |
| 3 Years | 18.30 | 63.69 | 17.96 | 32.96 | 60,181 | 9.24 | 50.49% |
| 5 Years | 18.30 | 63.69 | 17.96 | 32.96 | 60,181 | 9.24 | 50.49% |
Tarsus Pharmaceuticals Description
| Tarsus Pharmaceuticals Inc is a late clinical-stage biopharmaceutical company. It is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's lead candidate TP-03, is a novel drug that targets the Demodex mite nervous system to kill the mites. |
